Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction
Crossref DOI link: https://doi.org/10.1186/s12872-016-0283-6
Published Online: 2016-05-31
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Halvorsen, Sigrun
Jortveit, Jarle
Hasvold, Pål
Thuresson, Marcus
Øie, Erik
Funding for this research was provided by:
AstraZeneca Nordic
License valid from 2016-05-31